Nutrient quality
Oil-based curcuminoids and complementary joint botanicals provide coherent support. Modest unstandardized ginger and Boswellia limit dose depth.
A coherent oil-based mobility blend makes sense as a trial. The tiny supply and weak value are the main drawbacks.
A coherent oil-based mobility blend makes sense as a trial. The tiny supply and weak value are the main drawbacks.
| $ 19.98 |
Turmeric curcuminoids and tart cherry lead the formula, with lower amounts of Boswellia and ginger. The four ingredients fit a clear mobility purpose and each base amount is disclosed.
Softgel fat may aid turmeric absorption, but no specific delivery technology or standardization percentage is given. Boswellia and ginger also lack active-marker yields.
Only 15 servings are included, which may suit someone testing tolerance. Regular users get better value from the larger package of the same formulation.
Oil-based curcuminoids and complementary joint botanicals provide coherent support. Modest unstandardized ginger and Boswellia limit dose depth.
Every active amount is visible without a hidden blend. Botanical marker yields, complete directions, and inactive ingredients remain incomplete.
The aggregate rating is very strong and the evidence base is modest. Specific experience details are unavailable, so complaint patterns and purpose fit remain uncertain.
Oil-based turmeric and a focused design provide moderate value. Premium cost and weak supporting doses make competitiveness poor.
| Ingredient | Amount per serving |
|---|---|
Calories | 10 Calorie(s) |
Total Fat | 1 Gram(s) |
Total Carbohydrates | 1 Gram(s) |
Protein | 1 Gram(s) |
Tart Cherry powder | 200 mg |
enhanced Turmeric extract (Curcuminoids) | 200 mg |
Ginger extract | 80 mg |
Boswellia serrata extract | 100 mg |
A moderate curcuminoid dose comes in an oil-based softgel that may improve use. Exact standardization and a patented delivery system are not disclosed. Added joint botanicals offer some context for the premium, though turmeric value is still weak.
The smaller mobility package uses the same clearly measured but unstandardized ginger extract. Its amount falls below a typical effective daily target, and source details are sparse. A premium serving cost makes it inefficient when judged specifically for ginger.
The formula provides a Boswellia extract without disclosing boswellic acid strength or AKBA content. Softgel delivery may aid absorption, but the serving amount is low for an ordinary extract. The high cost per serving makes it poor value for Boswellia alone.